Financial News

Financial Report: INC Research/inVentiv Health

Combined Clinical Solutions Segment generated revenue of $533.4 million in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

INC Research/inVentiv Health 3Q Revenues: $822.3 million (+110%) 3Q Loss: $148 million (earnings were $27.3 million 3Q16) YTD Revenues: $1.6 billion (+32%) YTD Loss: $123.4 million (earnings were $75.1 million YTD16) Comments: INC Research completed the merger with inVentiv Health on August 1, 2017. Service revenue in the quarter was up 128% due to the Merger, partially offset by a decline in revenues due to continued customer and regulatory delays. Combined Clinical Solutions Segment gene...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters